Recruiting
Phase 1

Sacituzumab Govitecan & Capecitabine

Sponsor:

Henry Ford Health System

Code:

NCT06065371

Conditions

Gastrointestinal Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Capecitabine

Sacituzumab govetican

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-09-14. This information was provided to ClinicalTrials.gov by Henry Ford Health System on 2024-12-09.